NENCI, Giuseppe Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.745
AS - Asia 2.268
EU - Europa 1.992
SA - Sud America 261
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 46
Totale 7.447
Nazione #
US - Stati Uniti d'America 2.664
SG - Singapore 815
HK - Hong Kong 751
UA - Ucraina 488
IE - Irlanda 329
RU - Federazione Russa 291
BR - Brasile 199
CN - Cina 193
VN - Vietnam 178
SE - Svezia 160
IT - Italia 144
DE - Germania 141
FI - Finlandia 132
FR - Francia 122
GB - Regno Unito 84
TR - Turchia 83
KR - Corea 64
CA - Canada 42
IN - India 37
AR - Argentina 28
BD - Bangladesh 23
IQ - Iraq 19
PK - Pakistan 18
JP - Giappone 17
MX - Messico 16
NL - Olanda 16
PL - Polonia 15
ZA - Sudafrica 15
BE - Belgio 14
CH - Svizzera 13
ID - Indonesia 12
UZ - Uzbekistan 11
MY - Malesia 10
CO - Colombia 8
EG - Egitto 8
SA - Arabia Saudita 8
LB - Libano 7
VE - Venezuela 7
GR - Grecia 6
AT - Austria 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
MA - Marocco 5
PY - Paraguay 5
BG - Bulgaria 4
ES - Italia 4
LT - Lituania 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AO - Angola 3
BO - Bolivia 3
CL - Cile 3
HN - Honduras 3
HU - Ungheria 3
NI - Nicaragua 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
TN - Tunisia 2
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
IR - Iran 1
KW - Kuwait 1
ME - Montenegro 1
MM - Myanmar 1
MR - Mauritania 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 7.314
Città #
Hong Kong 751
Singapore 550
Chandler 342
Dublin 329
Jacksonville 270
San Jose 225
San Mateo 201
Ashburn 148
Boardman 113
Santa Clara 107
Moscow 99
Dong Ket 88
Medford 84
Princeton 84
Ann Arbor 79
Lauterbourg 75
Altamura 72
Izmir 69
Seoul 64
Wilmington 64
Beijing 52
Des Moines 49
Andover 48
Lawrence 43
Helsinki 36
Los Angeles 34
Munich 33
New York 32
Ho Chi Minh City 30
The Dalles 29
Piscataway 28
Saint Petersburg 23
Shanghai 21
Hanoi 19
Orem 15
Tokyo 15
Brussels 14
Montreal 14
Ottawa 14
Dallas 13
Frankfurt am Main 13
Norwalk 13
Perugia 13
Denver 12
São Paulo 12
Woodbridge 12
Houston 11
Turku 11
London 10
Toronto 9
Johannesburg 8
Macerata 8
Phoenix 8
San Francisco 8
Stockholm 8
Baghdad 7
Brooklyn 7
Council Bluffs 7
Den Haag 7
Atlanta 6
Auburn Hills 6
Cairo 6
Chennai 6
Da Nang 6
Manchester 6
San Paolo di Civitate 6
Amsterdam 5
Belo Horizonte 5
Charlotte 5
Chicago 5
Hải Dương 5
Kuala Lumpur 5
Mumbai 5
Poplar 5
Ankara 4
Buffalo 4
Dearborn 4
Dhaka 4
Guangzhou 4
Guayaquil 4
Kraków 4
Medellín 4
Mexico City 4
Philadelphia 4
Rio de Janeiro 4
San José 4
Warsaw 4
Barnet 3
Blumenau 3
Boston 3
Brasília 3
Casablanca 3
Catanduva 3
Chandigarh 3
Concord 3
Curitiba 3
Karachi 3
Karbala 3
La Paz 3
Lahore 3
Totale 4.733
Nome #
Fisiopatologia dell'emostasi 528
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 180
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 169
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 152
Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats 127
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 118
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 117
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 113
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 111
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 110
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 108
Choline plasmalogen biosynthesis by transmethylation in human platelets 108
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 107
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 105
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 105
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The EVEREST Trial 104
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 101
Risk factor for upper limb deep vein thrombosis 99
Profilassi della trombosi venosa profonda in neurochirurgia 97
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 96
Effect of different plasma expanders on erythrocyte filterability 96
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 95
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 95
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 94
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 94
Effect of pentoxifylline on platelet aggregation 93
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 92
Kidney failure and endothelial disfunction: effects of haemodialysis 91
Cholinephosphotransferase activity in human platelet 91
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial 90
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 89
Erythocyte deformability changes in normal pregnancy and preeclampsia 88
Diagnostica generale delle malattie emorragiche. 88
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial 87
Characterization of N, N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. 85
Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin -C treatment 83
Evaluation of the antithrombotic activity of unfractioned heparin or nadroparine after oral administration in man 82
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression 82
Risk factor for upper extremity deep vein thrombosis 81
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 80
Platelets release their lysosomal content in vivo in humans upon activation 78
Intrinsically defective or exhausted platelets in hairy cell leukemia? 77
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 76
Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism 76
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 76
High shear stress induces nitric oxide synthesis in human platelets - 75
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 75
Platelet activation and allergic asthma. 75
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures 75
Infusion of vincristine-loaded platelets in acute ITP refractory to steroids: an alternative to splenectomy 74
Human blood platelets release their lysosomal content ''in vivo'' at a localized site of platelet activation 74
Erythrocyte deformability in pre-eclamptic women and their newborn in the evaluation of microcirculatory impairment. 74
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 74
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. 73
Treatment of intermittent claudication with mesoglycan - a placebo-controlled, double - blind study. 73
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment 72
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement 72
Ultraviolet spectra of membrane-rich human platelet particulates. Normal data and specular abnormalities in hypo- and hyper-betalipoproteinemia 72
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders 68
Red cell deformability alterations in normal late pregnancy: possible role of plasma components 68
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 67
Evidence for platelet activation in allergic asthma. 66
Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. 66
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. 65
Thrombolytic therapy for thromboembolism of vertebrobasilar artery. 65
Vincristine-loaded platelets for autoimmune thrombocytopenic purpura 64
Platelets release lambda-granules (lysosomes) “in vivo” in humans upon activation 63
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic diseases. 62
Platelet glycohydrolase activities: characterization and release 62
Vinca-loaded platelets 60
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets. Role of adenylylcyclase up-regulation 59
Liquid Nitrogen Snap Frozen Saphenous Vein for Vascular Access in Dialysis 59
Platelets release lambda-granules (lysosomes) in vivo in humans upon activation 59
La safena omologa crioconservata come accesso dialitico: valutazione biologica e clinica 57
Interactions between platelets, other cells and eicosanoids in hypertension. 56
The reduced erythrocyte deformability in pre-eclampsia is due to altered plasma to red blood cell interactions 56
Treatment of intermittent claudication with medoglycan- a placebo-controlled, double-blind study 56
Heparin and local haemostasis 55
In vitro and ex vivo effect of indobufen on red blood cell deformability. 54
Ruolo del sistema emostatico nella patologia cardiovascolare. Generalità. 54
New pyridazinone derivatives as inhibitors of platelet aggregation. 51
Thromboxane does not play a significant role in acute, cold induced vasoconstriction in raynaud’s phenomenon 50
Platelets and asthma 50
Human blood platelets release their lysosomal content “in vivo” at a localised site of platelet activation 43
Platelet glycohydrolase activities: Characterization and release 40
Totale 7.447
Categoria #
all - tutte 32.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022632 0 117 18 27 20 2 6 234 5 16 71 116
2022/20231.149 96 195 26 84 83 140 0 51 417 1 34 22
2023/2024931 30 43 22 4 6 2 645 12 33 17 71 46
2024/20251.054 9 150 24 26 210 30 22 63 222 65 158 75
2025/20261.985 166 100 91 268 279 182 381 70 223 176 37 12
2026/202771 26 45 0 0 0 0 0 0 0 0 0 0
Totale 7.447